Biogen Reports Its Alzheimer’s Drug Sharply Slowed Cognitive Decline

Facebook
VKontakte
share_fav

The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.

view The New York Times: Science